BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12623109)

  • 21. Technetium-99m sestamibi single photon emission computed tomography findings correlated with P-glycoprotein expression, encoded by the multidrug resistance gene-1 messenger ribonucleic acid, in intracranial meningiomas.
    Kunishio K; Morisaki K; Matsumoto Y; Nagao S; Nishiyama Y
    Neurol Med Chir (Tokyo); 2003 Dec; 43(12):573-80; discussion 581. PubMed ID: 14723263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging multidrug resistance P-glycoprotein transport function using microPET with technetium-94m-sestamibi.
    Bigott HM; Prior JL; Piwnica-Worms DR; Welch MJ
    Mol Imaging; 2005; 4(1):30-9. PubMed ID: 15967124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination and prediction of P-glycoprotein and multidrug-resistance-related protein expression in breast cancer with double-phase technetium-99m sestamibi scintimammography. Visual and quantitative analyses.
    Kim IJ; Bae YT; Kim SJ; Kim YK; Kim DS; Lee JS
    Oncology; 2006; 70(6):403-10. PubMed ID: 17237619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response.
    Burak Z; Ersoy O; Moretti JL; Erinç R; Ozcan Z; Dirlik A; Sabah D; Basdemir G
    Eur J Nucl Med; 2001 Sep; 28(9):1341-50. PubMed ID: 11585293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Correlation of the uptake of technetium-99m methoxyisobutyl isonitrile with expression of multidrug resistance genes mdr-1 and MRP in human lung cancer].
    Shi D; Huang G; Miao J; Lin X
    Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(12):824-7. PubMed ID: 12126530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of chemotherapeutic response by Technetium 99m--MIBI scintigraphy in breast carcinoma patients.
    Takamura Y; Miyoshi Y; Taguchi T; Noguchi S
    Cancer; 2001 Jul; 92(2):232-9. PubMed ID: 11466674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of the P-glycoprotein expression by 99mTc-MIBI bone marrow imaging in patients with untreated leukaemia.
    Ak I; Aslan V; Vardareli E; Gülbaş Z
    Nucl Med Commun; 2003 Apr; 24(4):397-402. PubMed ID: 12673168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of chest single photon emission computed tomography with technetium-99m methoxyisobutylisonitrile to predict taxol based chemotherapy response in advanced non-small cell lung cancer.
    Shih CM; Hsu WH; Huang WT; Wang JJ; Ho ST; Kao A
    Cancer Lett; 2003 Sep; 199(1):99-105. PubMed ID: 12963129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation between technetium 99m-methoxyisobutylisonitrile accumulation and multidrug resistance protein in the parathyroid glands.
    Yamaguchi S; Yachiku S; Hashimoto H; Kaneko S; Nishihara M; Niibori D; Shuke N; Aburano T
    World J Surg; 2002 Jan; 26(1):29-34. PubMed ID: 11898030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between P-glycoprotein (P-gp) expression in parathyroid and Tc-99m MIBI parathyroid image findings.
    Sun SS; Shiau YC; Lin CC; Kao A; Lee CC
    Nucl Med Biol; 2001 Nov; 28(8):929-33. PubMed ID: 11711312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correlation between uptake of 99Tcm-MIBI and expression of multidrug resistant protein in breast cancer].
    Zhang XM; Zhang ZW; Wu H
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):353-5. PubMed ID: 15312346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detecting parathyroid adenoma using technetium-99m tetrofosmin: comparison with P-glycoprotein and multidrug resistance related protein expression--a preliminary report.
    Shiau YC; Tsai SC; Wang JJ; Ho ST; Kao A
    Nucl Med Biol; 2002 Apr; 29(3):339-44. PubMed ID: 11929704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Technetium-99m-sestamethoxyisobutylisonitrile scan as a predictor of chemotherapy response in malignant lymphomas compared with P-glycoprotein expression, multidrug resistance-related protein expression and other prognosis factors.
    Kao CH; Tsai SC; Wang JJ; Ho YJ; Ho ST; Changlai SP
    Br J Haematol; 2001 May; 113(2):369-74. PubMed ID: 11380401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 99mTc-MIBI SPET in non-small cell lung cancer in relationship with Pgp and prognosis.
    Yüksel M; Cermik TF; Doğanay L; Karlikaya C; Cakir E; Salan A; Berkarda S
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):876-81. PubMed ID: 12111127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein.
    Hendrikse NH; Franssen EJ; van der Graaf WT; Meijer C; Piers DA; Vaalburg W; de Vries EG
    Br J Cancer; 1998; 77(3):353-8. PubMed ID: 9472628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using technetium-99m methoxyisobutylisonitrile lung single-photon-emission computed tomography to predict response to chemotherapy and compare with P-glycoprotein expression in patients with untreated small cell lung cancer.
    Changlai SP; Tsai CS; Ding HJ; Huang WT; Kao A; Hsu WH
    Med Oncol; 2003; 20(3):247-53. PubMed ID: 14514974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 99mTc-MIBI Imaging in the presurgical characterization of thyroid follicular neoplasms: relationship to multidrug resistance protein expression.
    Saggiorato E; Angusti T; Rosas R; Martinese M; Finessi M; Arecco F; Trevisiol E; Bergero N; Puligheddu B; Volante M; Podio V; Papotti M; Orlandi F
    J Nucl Med; 2009 Nov; 50(11):1785-93. PubMed ID: 19837765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the uptake and clearance of Tc-99m MIBI, Tl-201 and Ga-67 in drug-resistant lymphoma cell lines.
    Tsai SC; Shiau YC; Wang JJ; Ho YJ; Kao CH
    Cancer Lett; 2001 Oct; 171(2):147-52. PubMed ID: 11520598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different Efflux Transporter Affinity and Metabolism of
    Kobayashi M; Tsujiuchi T; Okui Y; Mizutani A; Nishi K; Nakanishi T; Nishii R; Fukuchi K; Tamai I; Kawai K
    Pharm Res; 2018 Nov; 36(1):18. PubMed ID: 30498970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 99mTc-sestamibi to monitor treatment with antisense oligodeoxynucleotide complementary to MRP mRNA in human breast cancer cells.
    Kinuya S; Bai J; Shiba K; Yokoyama K; Mori H; Fukuoka M; Watanabe N; Shuke N; Michigishi T; Tonami N
    Ann Nucl Med; 2006 Jan; 20(1):29-34. PubMed ID: 16485571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.